Lee Pascoe, Sin Eugene, Yip Kam-Tong, Ng Kenneth
Department of Clinical Pathology, Tuen Mun Hospital, Hospital Authority, Hong Kong, China.
Pathogens. 2025 Mar 13;14(3):276. doi: 10.3390/pathogens14030276.
Neonatal sepsis is a major cause of infant mortality, and it accounts for a significant consumption of antimicrobials in paediatrics. This is the first comprehensive study on neonatal sepsis in Hong Kong.
From 2014 to 2023, all neonates admitted to a single institution with culture-proven infections from the blood and/or cerebrospinal fluid were selected and reviewed retrospectively. The infecting organisms, their antibiotic nonsusceptibility pattern, and the concordance of empirical antimicrobial therapy with the microbiological profiles were described and were further compared between infants of normal/low birth weight (≥1.5 kg) and very low/extremely low birth weight (<1.5 kg), early-onset sepsis (<72 h), and late-onset sepsis (4-28 days), the first and the second 5-year periods (2014-2018 vs. 2019-2023).
After contaminants were excluded, there were 118 affected neonates with 125 organisms identified. Fifty-nine were male. Thirty-four were very low/extremely low birth weight infants, and twenty-eight infants had early-onset sepsis. Patient demographics and the microbiology findings did not differ between the first 5 years and the latter 5 years. However, the incidence of neonatal sepsis was significantly lower in the latter 5 years (3.23 vs. 1.61 per 1000 live births, < 0.001), the period that coincided with the COVID-19 pandemic. was the most common Gram-negative pathogen. and group infections were more common in early-onset sepsis, while coagulase-negative and non- Gram-negative pathogens were more likely to occur in late-onset sepsis. In very low/extremely low birth weight infants, the rate of cefotaxime or ceftriaxone nonsusceptibility among Gram-negative isolates was higher ( = 0.01), and concordance of empirical antimicrobial therapy was lower ( = 0.006).
Management of neonatal sepsis remains challenging, and there is a need for optimising antimicrobial therapy, especially in preterm patients. Antepartum screening with intrapartum antibiotic prophylaxis is effective in reducing the risk of early-onset sepsis associated with , while stringent infection control measures are important for the prevention of late-onset sepsis.
新生儿败血症是婴儿死亡的主要原因,且在儿科领域抗菌药物的消耗中占很大比例。这是香港第一项关于新生儿败血症的全面研究。
选取2014年至2023年期间,在单一机构住院且血和/或脑脊液培养证实有感染的所有新生儿进行回顾性研究。描述感染病原体、它们的抗生素不敏感模式以及经验性抗菌治疗与微生物学特征的一致性,并在正常/低出生体重(≥1.5千克)和极低/超低出生体重(<1.5千克)的婴儿、早发型败血症(<72小时)和晚发型败血症(4 - 28天)、第一个和第二个5年期间(2014 - 2018年与2019 - 2023年)之间进行进一步比较。
排除污染物后,有118名受影响的新生儿,鉴定出125种病原体。59名是男性。34名是极低/超低出生体重婴儿,28名婴儿患有早发型败血症。前5年和后5年的患者人口统计学和微生物学结果没有差异。然而,后5年新生儿败血症的发病率显著较低(每1000例活产中分别为3.23例和1.61例,<0.001),这一时期与新冠疫情相吻合。大肠埃希菌是最常见的革兰阴性病原体。大肠埃希菌和B组链球菌感染在早发型败血症中更常见,而凝固酶阴性葡萄球菌和非革兰阴性病原体在晚发型败血症中更易发生。在极低/超低出生体重婴儿中,革兰阴性分离株对头孢噻肟或头孢曲松不敏感的发生率更高(P = 0.01),经验性抗菌治疗的一致性更低(P = 0.006)。
新生儿败血症的管理仍然具有挑战性,需要优化抗菌治疗,尤其是在早产儿中。产前筛查并进行产时抗生素预防可有效降低与大肠埃希菌相关的早发型败血症的风险,而严格的感染控制措施对于预防晚发型败血症很重要。